AstraZeneca drug approval
AstraZeneca received US regulatory approval for limited use of Iressa, its controversial experimental cancer drug, as a last resort treatment in some lung cancer patients. The US Food and Drug
AstraZeneca received US regulatory approval for limited use of Iressa, its controversial experimental cancer drug, as a last resort treatment in some lung cancer patients. The US Food and Drug